Stanozolol is a androgen and anabolic steroid (AAS) medication derived from dihydrotestosterone (DHT) and is used to treat hereditary angioedema.
It is used for physique and performance enhancing purposes by competitive athletes, bodybuilders, and power lifters.
Unlike most injectable AAS, stanozolol is not esterified and is sold as an aqueous suspension, or in oral tablet form. The drug has a high oral bioavailability, due to a C17 alfa alkylation which allows the hormone to survive first pass liver metabolism when ingested. It is because of this that stanozolol is also sold in tablet form.
Stanozolol is one of the AAS commonly used as performance enhancing drugs. It is an anabolic steroid that is known to have a diuretic effect.
It has been used with some success to treat venous insufficiency. It stimulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with stanozolol. It is also being studied to treat hereditary angioedema, osteoporosis, and skeletal muscle injury.
